Antidepressant withdrawal-induced activation (hypomania and mania): Mechanism and theoretical significance
Open accessAbstract
Electrocortical and behavioral arousal are separate phenomena subserved by different neural substrata operating in parallel. A comprehensive theory of 'activation' must take into account the relationships between the electrical and behavioral activating systems. In pathological or experimentally induced states paradoxes, resolvable by a theory positing functional interaction between these systems, arise. EEG arousal is directly mediated, in both the waking and sleeping state, by cholinergic mechanisms. Antidepressant withdrawal precipitates cholinergic overdrive; this would account for the apparent disturbances of REM sleep occurring when antidepressants are stopped. Generally, cholinergic overdrive would produce behavioral inhibition but in particular instances it triggers marked psychomotor arousal by mobilizing a 'limbic activating system'. The existence of a monoaminergic 'limbic activating system', system 'A', with the properties attributed to it in this paper, is supported by both clinical and laboratory observations. System 'A' theory provides a parsimonious means of adequately explaining many phenomena. This theory also has in its favor explanatory power and scope. The Cholinergic-Monoaminergic Interaction Theory of antidepressant withdrawal induced activation and of rapidly-cycling manic-depressive illness maintains that system 'A' and a cholinergic inhibitory system interact dynamically, and that excessive monoaminergic function can precipitate excessive cholinergic function and a dearth of monoaminergic function (due to autoregulation) and hence depression. Likewise, excessive cholinergic function is posited to activate monoaminergic systems and hence to secondarily cause behavioral activation. Rapidly-cycling manic-depressive patients, according to the model, develop alternating cholinergic and monoaminergic overdrive states because the homeostatic mechanisms which should serve to maintain, within normal limits, the composite of cholinergic inhibitory and monoaminergic activating influences are defective. Consequently, rather than reaching a reasonable balance compatible with adaptive function there is oscillation between extremes. Each oscillatory movement is actually a move towards the 'golden mean' and is induced by deviation from this ideal but the defective homeostatic mechanisms promote ' perpetual ' overshooting. Lithium and ECT may be useful in the treatment of rapidly-cycling patients as both treatments may down-regulate muscarinic receptors, and otherwise modify cholinergic and monoaminergic systems in ways promoting homeostasis.(ABSTRACT TRUNCATED AT 400 WORDS)
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Substituting diazepam with lorazepam has shown little evidence to support its efficacy.
“Some authors suggested tapering from other BZDs such as lorazepam after substituting diazepam [79], according to Murphy and Tyrer [80] such substitution has shown little evidence to support its efficacy.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [79]
The passages from §3.5 concern antidepressant-withdrawal activation and include references to benzodiazepine receptors, but do not discuss substituting diazepam with lorazepam or whether that substitution is effective. Searches for the drugs and for Murphy and Tyrer found no passage addressing the claim; page numbers were unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Brain stem reticular formation and activation of the EEG
Moruzzi, G., & Magoun, H. W. (1949) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(49)90219-9 · Cited by 4,307 · see citing works
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,499 · see citing works
The pharmacological basis of therapeutics
Frank, A. L. (1981) · Environmental Research · doi:10.1016/0013-9351(81)90176-6 · Cited by 2,738 · see citing works
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243 · see citing works
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415 · see citing works
Frontiers in Catecholamine Research
(1973) · Elsevier eBooks · doi:10.1016/c2013-0-02608-4 · Cited by 1,255 · see citing works
Sleep Cycle Oscillation: Reciprocal Discharge by Two Brainstem Neuronal Groups
Hobson, J. A., McCarley, R. W., & Wyzinski, P. (1975) · Science · doi:10.1126/science.1094539 · Cited by 1,238 · see citing works
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · see citing works
Norepinephrine in Depressive Reactions
Bunney, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,154 · see citing works
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134 · see citing works
Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in Brain
Burt, D. R., Creese, I., & Snyder, S. H. (1977) · Science · doi:10.1126/science.847477 · Cited by 1,027 · see citing works
BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROME
Bach, F. H., Albertini, R., Joo, P., Anderson, J., & Bortin, M. M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92672-x · Cited by 867 · see citing works
Meyler's Side Effects of Drugs
Breckenridge, A. (1976) · BMJ · doi:10.1136/bmj.2.6030.307 · Cited by 692 · see citing works
Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment
Charney, D. S. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780350094011 · Cited by 649 · see citing works
Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens
Pijnenburg, A. J. J., & van Rossum, J. M. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb09995.x · Cited by 480 · see citing works
Ontogeny of Adrenergic Arousal and Cholinergic Inhibitory Mechanisms in the Rat
Campbell, B. A., Lytle, L. D., & Fibiger, H. C. (1969) · Science · doi:10.1126/science.166.3905.635 · Cited by 468 · see citing works
Effect upon the EEG of acute injury to the brain stem activating system
Lindsley, D. B., Bowden, J. W., & Magoun, H. W. (1949) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(49)90221-7 · Cited by 443 · see citing works
Acetylcholine Liberation from Cerebral Cortex during Paradoxical (REM) Sleep
Jasper, H. H., & Tessier, J. (1971) · Science · doi:10.1126/science.172.3983.601 · Cited by 427 · see citing works
Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants
Wehr, T. A. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050065007 · Cited by 408 · see citing works
THE EFFECTS OF SOME DRUGS ON THE ELECTRICAL ACTIVITY OF THE BRAIN
Bradley, P. B., & Elkes, J. (1957) · Brain · doi:10.1093/brain/80.1.77 · Cited by 398 · see citing works
A cholinergic mechanism in the brainstem reticular formation: Induction of paradoxical sleep
George, R., Haslett, W. L., & Jenden, D. J. (1964) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(64)90076-0 · Cited by 397 · see citing works
BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC EFFECTS OF ATROPINE AND RELATED COMPOUNDS
Longo, V. G. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07156-x · Cited by 385 · see citing works
Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys
Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978) · Science · doi:10.1126/science.341313 · Cited by 373 · see citing works
Dexamethasone Suppression Tests in Antidepressant Treatment of Melancholia
Greden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 354 · see citing works
Self-citationSOMNOLENCE CAUSED BY HYPOTHALAMIC LESIONS IN THE MONKEY
Ranson, S. W. (1939) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1939.02270130011001 · Cited by 353 · see citing works
ASCENDING CONDUCTION IN RETICULAR ACTIVATING SYSTEM, WITH SPECIAL REFERENCE TO THE DIENCEPHALON
Starzl, T. E., Taylor, C. W., & Magoun, H. W. (1951) · Journal of Neurophysiology · doi:10.1152/jn.1951.14.6.461 · Cited by 337 · see citing works
Jackson, D. M., And�n, N.-E., & Dahlstr�m, A. (1975) · Psychopharmacology · doi:10.1007/bf00429052 · Cited by 322 · see citing works
Presynaptic Alpha-Receptor Subsensitivity After Long-Term Antidepressant Treatment
Crews, F. T., & Smith, C. B. (1978) · Science · doi:10.1126/science.211589 · Cited by 322 · see citing works
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-3-426_1 · Cited by 319 · see citing works
PSYCHIATRIC SEQUELÆ OF CHRONIC EXPOSURE TO ORGANOPHOSPHORUS INSECTICIDES
Gershon, S., & Shaw, F. H. (1961) · The Lancet · doi:10.1016/s0140-6736(61)92004-9 · Cited by 315 · see citing works
Limbic cholinergic pathways involved in sleep and emotional behavior
Hernández-Peón, R., Chávez-Ibarra, G., Morgane, P. J., & Timo-Iaria, C. (1963) · Experimental Neurology · doi:10.1016/0014-4886(63)90037-2 · Cited by 308 · see citing works
Receptor Adaptations to Centrally Acting Drugs
Creese, I., & Sibley, D. R. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.002041 · Cited by 293 · see citing works
Selective firing by cat pontine brain stem neurons in desynchronized sleep.
Hobson, J. A., McCarley, R. W., Pivik, R. T., & Freedman, R. (1974) · Journal of Neurophysiology · doi:10.1152/jn.1974.37.3.497 · Cited by 272 · see citing works
CAUDAL AND CEPHALIC INFLUENCES OF THE BRAIN STEM RETICULAR FORMATION
Magoun, H. W. (1950) · Physiological Reviews · doi:10.1152/physrev.1950.30.4.459 · Cited by 271 · see citing works
Wikler, A. (1952) · Experimental Biology and Medicine · doi:10.3181/00379727-79-19345 · Cited by 258 · see citing works
Further mapping out of central noradrenaline neuron systems: Projections of the ‘subcoeruleus’ area
Olson, L., & Fuxé, K. (1972) · Brain Research · doi:10.1016/0006-8993(72)90299-5 · Cited by 244 · see citing works
Sitaram, N., Nürnberger, J. I., Gershon, E. S., & Gillin, J. C. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.5.571 · Cited by 241 · see citing works
Bradley, P. B., & Key, B. J. (1958) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(58)90107-x · Cited by 230 · see citing works
Janowsky, D. S., El-Yousef, K. M., & Davis, J. M. (1974) · Psychosomatic Medicine · doi:10.1097/00006842-197405000-00008 · Cited by 230 · see citing works
Mesencephalic Reticular Activating System and Cortical Acetylcholine Output
Kanai, T., & Szerb, J. C. (1965) · Nature · doi:10.1038/205080b0 · Cited by 228 · see citing works
Parasympathetic Suppression of Manic Symptoms by Physostigmine
Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750340072012 · Cited by 225 · see citing works
Cortical acetylcholine release and electroencephalographic arousal
Szerb, J. C. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008303 · Cited by 218 · see citing works
Platelet α2-Adrenergic Receptors in Major Depressive Disorder
Garcı́a-Sevilla, J. A. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780370029003 · Cited by 216 · see citing works
Bergstrom, D. A., & Kellar, K. J. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31650-2 · Cited by 216 · see citing works
Chiodo, L. A., & Antelman, S. M. (1980) · Nature · doi:10.1038/287451a0 · Cited by 210 · see citing works
Alerting Responses and Actions of Atropine and Cholinergic Drugs
Rinaldi, F. (1955) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1955.02330100019005 · Cited by 203 · see citing works
Faster Cholinergic REM Sleep Induction in Euthymic Patients with Primary Affective Illness
Sitaram, N., Nürnberger, J. I., Gershon, E. S., & Gillin, J. C. (1980) · Science · doi:10.1126/science.7361118 · Cited by 194 · see citing works
The Pathophysiologic Basis of Tardive Dyskinesia
Baldessarini, R. J., & Tarsy, D. (1980) · Springer eBooks · doi:10.1007/978-94-011-6381-1_17 · Cited by 194 · see citing works
THE EFFECTS OF DIISOPROPYLFLUOROPHOSPHONATE IN SCHIZOPHRENIA AND MANIC DEPRESSIVE PSYCHOSIS
Rowntree, D. W., Nevin, S., & Wilson, A. (1950) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.13.1.47 · Cited by 185 · see citing works
CANNABIS-ASSOCIATED PSYCHOSIS WITH HYPOMANIC FEATURES
Rottanburg, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91270-3 · Cited by 179 · see citing works
Ehlert, F. J., Kokka, N., & Fairhurst, A. S. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14063-7 · Cited by 175 · see citing works
SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINKSTERASE ADMINISTRATION
HOWKRS, M. B., GOODMAN, E., & Sim, V. M. (1964) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196404000-00009 · Cited by 172 · see citing works
The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system
Costall, B., & Naylor, R. J. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90326-x · Cited by 166 · see citing works
Therapeutic Strategies Against Tardive Dyskinesia
Jeste, D. V. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070037008 · Cited by 160 · see citing works
Chiodo, L. A., & Antelman, S. M. (1980) · Science · doi:10.1126/science.6254148 · Cited by 158 · see citing works
Antidepressant withdrawal phenomena.
Dilsaver, S. C., & Greden, J. F. (1984) · PubMed · Cited by 156 · see citing works
Self-citationCholinergic modulation of adrenergic arousal in the developing rat.
Fibiger, H. C., Lytle, L. D., & Campbell, B. A. (1970) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0029741 · Cited by 153 · see citing works
Cohen, R. M. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90091-0 · Cited by 149 · see citing works
VANPRAAG, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90115-5 · Cited by 148 · see citing works
Dissociation of Electrocortical Activation and Behavioural Arousal
Feldman, S. M., & Waller, H. J. (1962) · Nature · doi:10.1038/1961320a0 · Cited by 147 · see citing works
Schiller, G. J. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90052-3 · Cited by 145 · see citing works
SPRIGGS, A. I. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90261-0 · Cited by 144 · see citing works
Risch, S. C., Cohen, R. M., Janowsky, D. S., Kalin, N. H., & Murphy, D. L. (1980) · Science · doi:10.1126/science.7433977 · Cited by 140 · see citing works
Burns, P. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92099-1 · Cited by 134 · see citing works
Antagonistic Effects of Physostigmine and Methylphenidate in Man
Janowsky, D. S., Davis, J. M., El‐Yousef, M. K., & SEKERKE, H. J. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.12.1370 · Cited by 132 · see citing works
Szerb, J. C. (1964) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y64-036 · Cited by 132 · see citing works
McCarley, R. W., & Hobson, J. A. (1971) · Science · doi:10.1126/science.174.4015.1250 · Cited by 131 · see citing works
Cholinergic Mechanism Involved in Function of Mesodiencephalic Activating System
Rinaldi, F. (1955) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1955.02330100028006 · Cited by 130 · see citing works
Cholinergic Challenges in Affective Illness
Risch, S. C., Kalin, N. H., & Janowsky, D. S. (1981) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198107000-00003 · Cited by 130 · see citing works
Influence of Demographic Characteristics on Two Measures of Depressive Symptoms
Craig, T. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780020039003 · Cited by 129 · see citing works
Abrupt Discontinuation of Tricyclic Antidepressant Drugs: Evidence for Noradrenergic Hyperactivity
Charney, D. S., Heninger, G. R., Sternberg, D. E., & Landis, D. H. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.141.4.377 · Cited by 126 · see citing works
Administration of an organophosphate causes a decrease in muscarinic receptor levels in rat brain
Gazit, H., Silman, I., & Dudai, Y. (1979) · Brain Research · doi:10.1016/0006-8993(79)90861-8 · Cited by 121 · see citing works
Scopolamine induces an increase in muscarinic receptor level in rat hippocampus
Ben-Barak, J., & Dudai, Y. (1980) · Brain Research · doi:10.1016/0006-8993(80)90973-7 · Cited by 119 · see citing works
Circadian and seasonal rhythms in α- and β-adrenergic receptors in the rat brain
Kafka, M. S., Wirz‐Justice, A., & Naber, D. (1981) · Brain Research · doi:10.1016/0006-8993(81)90373-5 · Cited by 118 · see citing works
Receptor alterations and drug tolerance
Overstreet, D. H., & Yamamura, H. I. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90607-6 · Cited by 117 · see citing works
Cholinergic activity regulates muscarinic receptors in central nervous system cultures.
Siman, R. G., & Klein, W. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.4141 · Cited by 115 · see citing works
Some effects of muscarinic cholinergic blocking drugs on behavior and the electrocorticogram
Meyers, B., Roberts, K. H., Riciputi, R. H., & Domino, E. F. (1964) · Psychopharmacology · doi:10.1007/bf02341261 · Cited by 114 · see citing works
Physostigmine induction of depressive symptomatology in normal human subjects
Risch, S. C., Cohen, R. M., Janowsky, D. S., Kalin, N. H., Sitaram, N., Christian Gillin, J., & Murphy, D. L. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90012-3 · Cited by 113 · see citing works
Clow, A., Theodorou, A. E., Jenner, P. G., & MARSDEN, C. D. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90438-0 · Cited by 113 · see citing works
Alterations in Motor Activity, Sleep, and Biochemistry in a Cycling Manic-Depressive Patient
Post, R. M. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770160104009 · Cited by 111 · see citing works
NEUROTRANSMITTER STUDIES OF NEUROENDOCRINE PATHOLOGY IN DEPRESSION
Carroll, B. J., Greden, J. F., Haskett, R. F., Feinberg, M. P., Albala, A. A., Martin, F. I. R., Rubín, R. T., Heath, B., Sharp, P. T., McLeod, W., et al. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.1980.61.s280.183 · Cited by 109 · see citing works
Self-citationVisualisation of 11C-flunitrazepam displacement in the brain of the live baboon
Comar, D., Mazière, M., Godot, J. M., Berger, G., Soussaline, F. P., Menini, C., Arfel, G., & Naquet, R. (1979) · Nature · doi:10.1038/280329a0 · Cited by 106 · see citing works
Russell, R. W., Overstreet, D. H., Cotman, C. W., Carson, V. G., Churchill, L., Dalglish, F. W., & Vásquez, B. J. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30032-7 · Cited by 105 · see citing works
Receptors, adenylate cyclase, depression, and lithium.
Belmaker, R. H. (1981) · PubMed · Cited by 101 · see citing works
Naber, D., Wirz‐Justice, A., Kafka, M. S., & Wehr, T. A. (1980) · Psychopharmacology · doi:10.1007/bf00426642 · Cited by 99 · see citing works
Hypomania and mania after withdrawal of tricyclic antidepressants
Mirin, S. M., Schatzberg, A. F., & Creasey, D. E. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.87 · Cited by 95 · see citing works
Beani, L., Bianchi, C., Santinoceto, L., & Marchetti, P. (1968) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(68)90046-4 · Cited by 94 · see citing works
Behavior during hippocampal microinfusions. I. Norepinephrine and diversive exploration
Flicker, C., & Geyer, M. A. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90006-6 · Cited by 94 · see citing works
Effect of Lithium on Circadian Neurotransmitter Receptor Rhythms
Kafka, M. S., Wirz‐Justice, A., Naber, D., Marangos, P. J., O’Donohue, T. L., & Wehr, T. A. (2008) · Neuropsychobiology · doi:10.1159/000117876 · Cited by 93 · see citing works
Seizures down-regulate muscarinic cholinergic receptors in hippocampal formation
Dasheiff, R. M., Savage, D. D., & McNamara, J. O. (1982) · Brain Research · doi:10.1016/0006-8993(82)91011-3 · Cited by 91 · see citing works
Rehavi, M., Ramot, O., Yaavetz, B., & Sokolovsky, M. (1980) · Brain Research · doi:10.1016/0006-8993(80)91224-x · Cited by 90 · see citing works
EFFECTS OF ESERINE, ACETYLCHOLINE AND ATROPINE ON THE ELECTROCORTICOGRAM
Miller, F. R., STAVRAKY, G. W., & Woonton, G. A. (1940) · Journal of Neurophysiology · doi:10.1152/jn.1940.3.2.131 · Cited by 89 · see citing works
Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings].
Ds, J., Risch, C., Parker, D., Huey, L. Y., & Judd, L. L. (1980) · PubMed · Cited by 89 · see citing works
Longo, V. C. (1956) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11738-2 · Cited by 86 · see citing works
Sitaram, N., & Gillin, J. C. (1980) · PubMed · Cited by 86 · see citing works
beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms.
Sc, R. (1982) · PubMed · Cited by 86 · see citing works
Cholinergic suppression of tardive dyskinesia
FANN, W. E., Lake, C. R., Gerber, C. J., & McKenzie, G. M. (1974) · Psychopharmacology · doi:10.1007/bf00437417 · Cited by 85 · see citing works
Muscarinic supersensitivity: A possible model for the sleep disturbance of primary depression?
Gillin, J. C., Sitaram, N., & Duncan, W. C. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90023-4 · Cited by 85 · see citing works
Regulation of Muscarinic Acetylcholine Receptor Concentration in Cloned Neuroblastoma Cells
Shifrin, G. S., & Klein, W. L. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb09676.x · Cited by 85 · see citing works
ACTION OF ESERINE AND AMPHETAMINE ON THE ELECTRICAL ACTIVITY OF THE RABBIT BRAIN
Longo, V. G., & Silvestrini, B. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11840-5 · Cited by 85 · see citing works
Andersson, K., Fuxé, K., & Agnati, L. F. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06827.x · Cited by 80 · see citing works
CENTRAL NERVOUS SYSTEM EFFECTS OF HYOSCINE IN MAN
Ostfeld, A. M., & Aruguete, A. (1962) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26335-2 · Cited by 79 · see citing works
The administration of di-isopropyl fluorophosphate (DFP) to man.
Grob, D., & Lilienthal, J. L. (1947) · PubMed · Cited by 78 · see citing works
Cholinergic antagonism of methylphenidate-induced stereotyped behavior
Janowksy, D. S., El‐Yousef, M. K., Davis, J. M., & SEKERKE, H. J. (1972) · Psychopharmacology · doi:10.1007/bf00429382 · Cited by 77 · see citing works
Antidepressant Withdrawal Syndromes
Dilsaver, S. C., Kronfol, Z., Sackellares, J. C., & Greden, J. F. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198306000-00003 · Cited by 77 · see citing works
Self-citationThe effect of lithium on acetylcholine release and synthesis
Vizi, E. S., Illéš, P., Rónai, A. Z., & Knoll, J. E. (1972) · Neuropharmacology · doi:10.1016/0028-3908(72)90007-x · Cited by 74 · see citing works
Bradley, P. B., & Elkes, J. (1953) · PubMed · Cited by 74 · see citing works
Balldin, J., Gran�rus, A. K., Lindstedt, G., Modigh, K., & W�linder, J. (1982) · Psychopharmacology · doi:10.1007/bf00449127 · Cited by 70 · see citing works
Hughes, R. (1976) · Neuropharmacology · doi:10.1016/0028-3908(76)90035-6 · Cited by 67 · see citing works
Longoni, R., Mulas, A., Novak, B. O., Pepeu, I. M., & Pepeu, G. (1976) · Neuropharmacology · doi:10.1016/0028-3908(76)90129-5 · Cited by 67 · see citing works
Antidepressant withdrawal symptoms treated with anticholinergic agents
Dilsaver, S. C., Feinberg, M. P., & Greden, J. F. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.2.249 · Cited by 67 · see citing works
Self-citationA biphasic action of central cholinergic stimulation on behavioral arousal in the rat
Fibiger, H. C., LYNCH, G. S., & Cooper, H. P. (1971) · Psychopharmacology · doi:10.1007/bf00403568 · Cited by 65 · see citing works
Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subiects
Sagalés, T., Erill, S., & Domino, E. F. (1969) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1969104522 · Cited by 63 · see citing works
Effect of amantadine on cerebral acetyl-choline release and content in the guinea pig
Beani, L., & Bianchi, C. (1973) · Neuropharmacology · doi:10.1016/0028-3908(73)90087-7 · Cited by 63 · see citing works
Antidepressant Withdrawal Syndromes
Dilsaver, S. C., & Greden, J. F. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198310000-00031 · Cited by 62 · see citing works
Self-citationEffect of Calcium Ions on the Release of Acetylcholine from the Cerebral Cortex
Randić, M., & Padjen, A. L. (1967) · Nature · doi:10.1038/215990a0 · Cited by 62 · see citing works
Receptors and the mechanism of action of ECT.
Lerer, B., & Belmaker, R. H. (1982) · PubMed · Cited by 60 · see citing works
Cholinergic mechanisms involved in cortical activation during arousal
Montplaisir, J. Y. (1975) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(75)90247-3 · Cited by 59 · see citing works
Dopamine binding following prolonged haloperidol pretreament
Hitri, A., Weiner, W. J., Borison, R. L., Diamond, B. I., Nausieda, P. A., & Klawans, H. L. (1978) · Annals of Neurology · doi:10.1002/ana.410030208 · Cited by 59 · see citing works
CHOLINERGIC REVERSAL OF MANIC SYMPTOMS
Carroll, B. J., Frazer, A., Schless, A. P., & Mendels, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90285-7 · Cited by 57 · see citing works
CHOLINERGIC ASPECTS OF CONVULSIVE THERAPY
Fink, M. (1966) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196605000-00012 · Cited by 56 · see citing works
Siever, L. J., Uhde, T. W., & Murphy, D. L. (1982) · Psychiatry Research · doi:10.1016/0165-1781(82)90019-1 · Cited by 56 · see citing works
Comar, D., Zarifian, E., Verhas, M., Soussaline, F. P., Mazière, M., Berger, G., Lôo, H., Cuche, H., Kellershohn, C., & Deniker, P. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90024-6 · Cited by 55 · see citing works
Andén, N., & Jackson, D. M. (1975) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1975.tb09529.x · Cited by 55 · see citing works
The Effect of Atropine and Related Drugs on the EEG and Behaviour
Bradley, P. B. (1968) · Progress in brain research · doi:10.1016/s0079-6123(08)64538-0 · Cited by 54 · see citing works
Electroconvulsive shock, brain acetylcholinesterase activity and memory
Adams, H. E., Hoblit, P. R., & Sutker, P. B. (1969) · Physiology & Behavior · doi:10.1016/0031-9384(69)90024-9 · Cited by 54 · see citing works
Physostigmine and lithium response in the schizophrenias
Edelstein, P., Schultz, J. R., Hirschowitz, J., Kanter, D. R., & Garver, D. L. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.8.1078 · Cited by 53 · see citing works
Lithium Reduces the Number of Acetylcholine Receptors in Skeletal Muscle
Pestronk, A., & Drachman, D. B. (1980) · Science · doi:10.1126/science.7423198 · Cited by 52 · see citing works
Induction of Severe Depression by Physostigmine in Marijuana Intoxicated Individuals*
El‐Yousef, M. K., Janowsky, D. S., Davis, J. M., & Rosenblatt, J. E. (1973) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1973.tb01264.x · Cited by 52 · see citing works
A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
Friedhoff, A. J., & Alpert, M. (1973) · PubMed · Cited by 52 · see citing works
Russell, R. W., Carson, V. G., Booth, R. A., & Jenden, D. J. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90064-2 · Cited by 51 · see citing works
Risch, S., Kalin, N., Janowsky, D., Cohen, R. M., Pickar, D., & Murphy, D. (1983) · Science · doi:10.1126/science.6312560 · Cited by 50 · see citing works
[Alpha waves studied from the point of view of Pavlovian cerebral physiology].
Popov, C. (1955) · PubMed · Cited by 50 · see citing works
Physostigmine-induced escape from dexamethasone suppression in normal adults.
Doerr, P., & Berger, M. (1983) · PubMed · Cited by 50 · see citing works
Circadian acetylcholine receptor rhythm in rat brain and its modification by imipramine
Kafka, M. S., Wirz‐Justice, A., Naber, D., & Wehr, T. A. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90171-4 · Cited by 49 · see citing works
Serial dexamethasone suppression tests among rapidly cycling bipolar patients.
Jf, G., DeVigne, J.-P., Albala, A. A., Tarika, J., Buttenheim, M., Eiser, A. S., & Carroll, B. J. (1982) · PubMed · Cited by 49 · see citing works
Behavior during hippocampal microinfusions. II. Muscarinic locomotor activation
Flicker, C., & Geyer, M. A. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90007-8 · Cited by 48 · see citing works
Depolarisation-induced changes in muscarinic cholinergic receptors in synaptosomes
Luqmani, Y. A., Bradford, H. F., Birdsall, N. J. M., & Hulme, E. C. (1979) · Nature · doi:10.1038/277481a0 · Cited by 48 · see citing works
Wheeler, S. C., & Roth, R. H. (1980) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00569724 · Cited by 48 · see citing works
How generalizable are the results of clinical trials?
Nr, S. (1980) · PubMed · Cited by 48 · see citing works
Telencephalo-diencephalic aspects of sleep mechanisms
Parmeggiani, P. L. (1968) · Brain Research · doi:10.1016/0006-8993(68)90002-4 · Cited by 45 · see citing works
Trihexyphenidyl (Artane) Abuse: Euphoriant and Anxiolytic
Kaminer, Y., Munitz, H., & Wijsenbeek, H. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.140.5.473 · Cited by 45 · see citing works
Clorgycline delays the phase-position of circadian neurotransmitter receptor rhythms
Wirz‐Justice, A., Kafka, M. S., Naber, D., Campbell, I. C., Marangos, P. J., Tamarkin, L., & Wehr, T. A. (1982) · Brain Research · doi:10.1016/0006-8993(82)91234-3 · Cited by 43 · see citing works
Biochemistry of Affective Disorders
Aillon, G. A. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71517-5 · Cited by 42 · see citing works
Evidence for an agonist independent down regulation of hippocampal muscarinic receptors in kindling
Dasheiff, R. M., & McNamara, J. O. (1980) · Brain Research · doi:10.1016/0006-8993(80)90070-0 · Cited by 41 · see citing works
BOLIN, R. R. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196009000-00008 · Cited by 40 · see citing works
Cholinergic transmission regulates extrajunctional acetylcholine receptors
Pestronk, A., Drachman, D. B., Stanley, E. F., Price, D. L., & Griffin, J. W. (1980) · Experimental Neurology · doi:10.1016/0014-4886(80)90193-4 · Cited by 37 · see citing works
THE EFFECTS OF MORPHINE, ATROPINE AND SCOPOLAMINE ON HUMAN SUBJECTS
Wangeman, C. P., & Hawk, M. H. (1942) · Anesthesiology · doi:10.1097/00000542-194201000-00003 · Cited by 36 · see citing works
Kremer, M. (1942) · Quarterly Journal of Experimental Physiology and Cognate Medical Sciences · doi:10.1113/expphysiol.1942.sp000867 · Cited by 36 · see citing works
Hypomania after desipramine withdrawal
Nelson, J. C., Schottenfeld, R. S., & Conrad, C. D. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.5.624 · Cited by 35 · see citing works
Physostigmine test in the rabbit syndrome and tardive dyskinesia
Weiss, K. J., Ciraulo, D. A., & Shader, R. I. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.5.627 · Cited by 34 · see citing works
Jellinek, T. (1977) · PubMed · Cited by 32 · see citing works
The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents
DOLPHIN, A. C., Jenner, P. G., Sawaya, M. C. B., MARSDEN, C. D., & Testa, B. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11450.x · Cited by 30 · see citing works
Gillespie, D. D., Dh, M., & Sulser, F. (1979) · PubMed · Cited by 30 · see citing works
Pl, P. (1962) · PubMed · Cited by 30 · see citing works
Rebound Phenomena in Manic Patients following Physostigmine
Shopsin, B., Janowsky, D. S., Davis, J., & Gershon, S. (2008) · Neuropsychobiology · doi:10.1159/000117490 · Cited by 29 · see citing works
Yoshimura, H., Fujiwara, M., & Ueki, S. (1974) · Brain Research · doi:10.1016/0006-8993(74)90854-3 · Cited by 29 · see citing works
Adverse interaction between disulfiram and marijuana: a case report
Lacoursiere, R. B., & Swatek, R. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.2.243 · Cited by 29 · see citing works
PARASYMPATHETIC REGULATION OF HIGH POTENTIAL IN THE ELECTROENCEPHALOGRAM
Darrow, C. W., Green, J. R., Davis, E. W., & Garol, H. W. (1944) · Journal of Neurophysiology · doi:10.1152/jn.1944.7.4.217 · Cited by 29 · see citing works
Convulsive seizures and electroencephalogram changes in three patients during levodopa therapy
McPHERSON, A. (1970) · Neurology · doi:10.1212/wnl.20.12_part_2.41 · Cited by 29 · see citing works
Behavior during hippocampal microinfusions. III. Lidocaine versus picrotoxin
Flicker, C., & Geyer, M. A. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90008-x · Cited by 28 · see citing works
Zur Frage der Beeinflussung schizophrener Symptome durch Physostigmin
Modestin, J., Schwartz, R. B., & Hunger, J. (1973) · Pharmacopsychiatry · doi:10.1055/s-0028-1094395 · Cited by 28 · see citing works
Abuse of antiparkinsonism drugs. Feigning of extrapyramidal symptoms to obtain trihexyphenidyl
Rubinstein, J. S. (1978) · JAMA · doi:10.1001/jama.239.22.2365 · Cited by 28 · see citing works
Serial dexamethasone suppression tests among rapidly cycling bipolar patients
Greden, J. F., DeVigne, J.-P., Albala, A. A., Tarika, J., Buttenheim, M., Eiser, A. S., & Bj, C. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198212000-00031 · Cited by 26 · see citing works
Self-citationPapp, M. I., & Bozsik, G. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb09876.x · Cited by 26 · see citing works
White, R. P., Rinaldi, F., & Himwich, H. E. (1956) · Journal of Applied Physiology · doi:10.1152/jappl.1956.8.6.635 · Cited by 26 · see citing works
Development of behavioral tolerance: A search for subcellular mechanisms
Russell, R. W., Carson, V. G., Jope, R. S., Booth, R. A., & Macri, J. (1979) · Psychopharmacology · doi:10.1007/bf00427623 · Cited by 25 · see citing works
EFFECT OF ATROPINE, SCOPOLAMINE AND MEPERIDINE ON MAN
Orkin, L. R., Bergman, P. S., & Nathanson, M. (1956) · Anesthesiology · doi:10.1097/00000542-195601000-00005 · Cited by 25 · see citing works
A Second Generation Catecholamine Hypothesis
Bunney, W. E., & GARLAND, B. L. (1982) · Pharmacopsychiatry · doi:10.1055/s-2007-1019521 · Cited by 24 · see citing works
Meter, W. G. V., & Karczmar, A. G. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90066-9 · Cited by 23 · see citing works
Myoclonic attacks induced by L-Dopa and Bromocryptin in Parkinson patients
Vardi, J., Glaubman, H., Rabey, J. M., & Streifler, M. (1978) · Journal of Neurology · doi:10.1007/bf00314716 · Cited by 23 · see citing works
Pathophysiology of Tardive Dyskinesia
Gunne, L. M., & Häggström, J. ‐. (1985) · Psychopharmacology series · doi:10.1007/978-3-642-70140-5_23 · Cited by 22 · see citing works
Transsynaptic regulation of tyrosine hydroxylase
Thoenen, H., Otten, U., & Oesch, F. (1973) · Life Sciences · doi:10.1016/0024-3205(73)90402-5 · Cited by 22 · see citing works
Reduced presynaptic dopamine receptor density after chronic antidepressant treatment in rats
Lee, T., & Tang, S. W. (1982) · Psychiatry Research · doi:10.1016/0165-1781(82)90059-2 · Cited by 22 · see citing works
Effect of Lithium Ions on the Release of Acetylcholine from the Cerebral Cortex
Bjegović, M., & Randić, M. (1971) · Nature · doi:10.1038/230587a0 · Cited by 22 · see citing works
The Nature of Muscarinic Receptor Binding
Ehlert, F. J., Roeske, W. R., & Yamamura, H. I. (1983) · Springer eBooks · doi:10.1007/978-1-4684-4361-5_6 · Cited by 21 · see citing works
Effects of delta 9-tetrahydrocannabinol on excitable membranes and neuromuscular transmission.
Kumbaraci, N. M., & Nastuk, W. L. (1980) · PubMed · Cited by 21 · see citing works
Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice
Riffee, W. H. (1976) · Neuropharmacology · doi:10.1016/0028-3908(76)90036-8 · Cited by 21 · see citing works
A cholinergic role in the mechanism of lithium in mania.
Gd, T., & Senogles, S. E. (1983) · PubMed · Cited by 21 · see citing works
Regulation of catecholamine release. The muscarinic inhibitory mechanism
Muscholl, E. (1973) · Life Sciences · doi:10.1016/0024-3205(73)90100-8 · Cited by 20 · see citing works
Behavior during hippocampal microinfusions. IV. Transmitter interactions
Flicker, C., & Geyer, M. A. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90009-1 · Cited by 18 · see citing works
Norepinephrine synthesis and turnover in the brain: Acceleration by physostigmine
Kažć, T. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90124-5 · Cited by 18 · see citing works
Clinical Efficacy of the Newer Antidepressants
Feighner, J. P. (1981) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198111001-00005 · Cited by 17 · see citing works
Presynaptic effects of lithium on cholinergic synaptic transmission in aplysia neurons
Waziri, R. (1968) · Life Sciences · doi:10.1016/0024-3205(68)90160-4 · Cited by 17 · see citing works
The local action of eserine on the central nervous system
Miller, F. R. (1937) · The Journal of Physiology · doi:10.1113/jphysiol.1937.sp003553 · Cited by 17 · see citing works
Eserine and Amphetamine: Interactive Effects on Sleeping Time in Mice
Barnes, C. D., & Meyers, F. H. (1964) · Science · doi:10.1126/science.144.3623.1221 · Cited by 15 · see citing works
Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate
Jones, D. L., Berg, S. L., Dorris, R. L., & Dill, R. E. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90183-0 · Cited by 15 · see citing works
A POLYGRAPHIC STUDY ON THE EFFECT OF ATROPINE ON HUMAN NOCTURNAL SLEEP
Toyoda, T., Sasaki, K., & Kurihara, M. (1966) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1966.tb01228.x · Cited by 15 · see citing works
The pathophysiology of tardive dyskinesia.
Klawans, H. L., Carvey, P. M., Tanner, C. M., & Goetz, C. (1985) · PubMed · Cited by 14 · see citing works
NOREPINEPHRINE SYNTHESIS AND TURNOVER IN THE BRAIN: ACCELERATION BY PHYSOSTIGMINE
Kažić, T. (1973) · Elsevier eBooks · doi:10.1016/b978-0-08-017922-3.50170-2 · Cited by 14 · see citing works
Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser
Dilsaver, S. C., Leckrone, J., & Greden, J. F. (1984) · Psychosomatics · doi:10.1016/s0033-3182(84)72999-9 · Cited by 13 · see citing works
Self-citationAn appraisal of hyoscine as an EEG activating agent
Vas, C. J., Exley, K. A., & Parsonage, M. J. (1967) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(67)90207-6 · Cited by 10 · see citing works
Tl, B., Babb, M. I., Mahnke, J. H., & Verzeano, M. (1971) · PubMed · Cited by 10 · see citing works
Effects of caffeine on tactile startle in rats
Ward, H., Pollare, T., & Geyer, M. A. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90046-0 · Cited by 9 · see citing works
The augmentation of physostigmine toxicity in the rat by 9 -tetrahydrocannabinol.
Rosenblatt, J. E., Janowsky, D. S., Davis, J. M., & El‐Yousef, M. K. (1972) · PubMed · Cited by 9 · see citing works
Do antidepressants induce dopamine autoreceptor subsensitivity? (reply)
Chiodo, L. A., & Antelman, S. M. (1982) · Nature · doi:10.1038/298302b0 · Cited by 7 · see citing works
Effects of anticholinergic drugs on epileptic activity from amygdala and frontal cortex
Vas, C. J., Delgado, J. M. R., & Glaser, G. H. (1969) · Neurology · doi:10.1212/wnl.19.3.234 · Cited by 7 · see citing works
Activation of the EEG by Procyclidine Hydrochloride in Temporal Lobe Epilepsy
Vas, C. J., Exley, K. A., & Parsonage, M. J. (1967) · Epilepsia · doi:10.1111/j.1528-1157.1967.tb04440.x · Cited by 7 · see citing works
OBSERVATIONS ON THE EFFECTS OF JB-329 (DITRAN) ON THE ELECTROENCEPHALOGRAM OF MAN.
Wp, W., & Jl, H. (1964) · PubMed · Cited by 7 · see citing works
Methixene Hydrochloride as an EEG Activating Agent
Vas, C. J., Exley, K. A., & Parsonage, M. J. (1967) · Epilepsia · doi:10.1111/j.1528-1157.1967.tb04441.x · Cited by 6 · see citing works
Flagged first, then by citations
5 of the 207 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- Dilsaver, S. C.. Leckrone, J. G. and Greden, J. F.. An 'anticholinesterase-like' syndrome precipitated by psy- chotropic withdrawal in a chronic abuser of marijuana, Psychosomatics, in press.
- Dilsaver, S. C. and Greden. J. F., Antidepressant with- drawal phenomena: a review. Biol. Psychiarry, 19 (1984) 237-256.
- Klaassen. C. D., Principles of toxicology. In A. G. Gil- man, L. S. Goodman and A. Gilman, (Ed%), The Phar- macological Basis of Therapeutics, 6th edn., Edition Mac- millan, New York, 1980, pp. 1608. 111
- Lindsley, D. B. In J. Field (Ed.), Handbook of Physiolo- gy, Sect. 1,3, 1553, (American Physiology Society, Wash- ington D. C., 1960). 118
- Weiner, N., Norepinephrine, epinephrine and the sympa- thomimetic amines. In A. G. Gilman L. S. Goodman and A. Gilman (Eds.), The Pharmacological Basis of Thera- peutics, 6th edn., MacMillan, New York, 1980,161 pp. 199
- Westfall, T. C., Effect of acetylcholine on the release of ~H3]norepineph~ne by nicotine and potassium chloride from rat brain slices. In E. Usdin and S. H. Snyder (Eds.), Frontiers of Catecholamine Research, Pergamon Press, New York, 1973,617-618 pp. 201
Cited by
Sorted by citations
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.2.201 · Cited by 346 · see citing works
Antidepressant‐induced mania: an overview of current controversies
Goldberg, J. F., & Truman, C. J. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00067.x · Cited by 310 · see citing works
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287 · see citing works
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Cholinergic mechanisms in depression
Dilsaver, S. C. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90016-0 · Cited by 174 · see citing works
Self-citationOverstreet, D. H., Puciłowski, O., Rezvani, A. H., & Janowsky, D. S. (1995) · Psychopharmacology · doi:10.1007/bf02245589 · Cited by 161 · see citing works
RAPID-CYCLING BIPOLAR DISORDER
Kilzieh, N., & Akiskal, H. S. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70097-6 · Cited by 143 · see citing works
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Caldecott-Hazard, S., Morgan, D., DeLeon-Jones, F. A., Overstreet, D. H., & Janowsky, D. S. (1991) · Synapse · doi:10.1002/syn.890090404 · Cited by 124 · see citing works
Healy, D. (1987) · Psychopharmacology · doi:10.1007/bf00187243 · Cited by 123 · see citing works
Possible role of antidepressants in precipitating mania and hypomania in recurrent depression
Kupfer, D. J., Carpenter, L. L., & Frank, E. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.7.804 · Cited by 105 · see citing works
Stress-induced immobility in rats with cholinergic supersensitivity
Overstreet, D. H., Janowsky, D. S., Gillin, J. C., Shiromani, P. J., & Sutin, E. L. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90127-7 · Cited by 92 · see citing works
Sleep-Loss as a Possible Mediator of Diverse Causes of Mania
Wehr, T. A. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.4.576 · Cited by 86 · see citing works
Antidepressant Withdrawal Syndrome
Lejoyeux, M., Adès, J., Mourad, I., Solomon, J., & Dilsaver, S. C. (1996) · CNS Drugs · doi:10.2165/00023210-199605040-00006 · Cited by 82 · see citing works
Self-citationGenetic and pharmacological models of cholinergic supersensitivity and affective disorders
Overstreet, D. H., Russell, R. W., Crocker, A. D., Gillin, J. C., & Janowsky, D. S. (1988) · Cellular and Molecular Life Sciences · doi:10.1007/bf01958920 · Cited by 78 · see citing works
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73 · see citing works
Attention deficit disorder and allergy: A neurochemical model of the relation between the illnesses.
Marshall, P. (1989) · Psychological Bulletin · doi:10.1037/0033-2909.106.3.434 · Cited by 72 · see citing works
Pharmacotherapy of depression and mixed states in bipolar disorder
Montgomery, S., Schatzberg, A. F., Guelfi, J., Kasper, S. F., Nemeroff, C. B., Swann, A. C., & Zajecka, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00178-6 · Cited by 61 · see citing works
Withdrawal phenomena associated with antidepressant and antipsychotic agents
Dilsaver, S. C. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00002 · Cited by 60 · see citing works
Self-citationStress induces supersensitivity of a cholinergic system in rats
Dilsaver, S. C., Snider, R. M., & Alessi, N. E. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90294-5 · Cited by 50 · see citing works
Self-citationNarayan, V., & Haddad, P. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359094 · Cited by 48 · see citing works
The Adrenergic-Cholinergic Imbalance Hypothesis of Depression: A Review and a Perspective
Fritze, J. (1993) · Reviews in the Neurosciences · doi:10.1515/revneuro.1993.4.1.63 · Cited by 47 · see citing works
Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology
Dilsaver, S. C. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06293.x · Cited by 46 · see citing works
Self-citationTwo cases of factitious acquired immune deficiency syndrome
Miller, F. W., Weiden, P. L., Sacks, M., & Wozniak, J. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1483 · Cited by 45 · see citing works
Ali, O., & Milev, R. V. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800410 · Cited by 41 · see citing works
Overstreet, D. H., Double, K. L., & Schiller, G. D. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90260-8 · Cited by 42 · see citing works
Effects of antidepressant withdrawal on the dexamethasone suppression test
Dilsaver, S. C., & Greden, J. F. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90055-1 · Cited by 41 · see citing works
Self-citationO’Keane, V., O’Flynn, K., Lucey, J. V., & Dinan, T. G. (1992) · Psychological Medicine · doi:10.1017/s0033291700032724 · Cited by 38 · see citing works
Effects of stress on muscarinic mechanisms
Dilsaver, S. C. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80070-8 · Cited by 37 · see citing works
Self-citationHeterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena
Dilsaver, S. C. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90097-z · Cited by 36 · see citing works
Self-citationvan Sweden, B. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90052-1 · Cited by 35 · see citing works
Cholinergic mechanisms in affective disorders
Dilsaver, S. C. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb06250.x · Cited by 34 · see citing works
Self-citationWithdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
Duncan, J. S., Shorvon, S. D., & Trimble, M. R. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.7.924 · Cited by 33 · see citing works
CHOLINERGIC DYSFUNCTION IN DEPRESSION
Janowsky, D. S., & Overstreet, D. H. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb02077.x · Cited by 33 · see citing works
Drug-Induced Mania - Causative Agents,Clinical Characteristics and Management
Sultzer, D. L., & Cummings, J. L. (1989) · Drug Safety · doi:10.1007/bf03259908 · Cited by 33 · see citing works
Temperature as a dependent variable in the study of cholinergic mechanisms
Dilsaver, S. C., & Alessi, N. E. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90058-9 · Cited by 32 · see citing works
Self-citationPhysostigmine-induced epinephrine release in patients with affective disorder
Janowsky, D. S., Sc, R., Ziegler, M. G., Gillin, J. C., Huey, L. Y., & Rausch, J. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.7.919 · Cited by 27 · see citing works
Mirtazapine withdrawal causing hypomania
MacCall, C. A., & Callender, J. S. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.4.390a · Cited by 24 · see citing works
Rothschild, A. J. (1988) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30744-1 · Cited by 20 · see citing works
Cholinergic properties of desipramine and amoxapine: Assessment using a thermoregulation paradigm
Dilsaver, S. C., & Davidson, R. K. (1987) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(87)90020-0 · Cited by 16 · see citing works
Self-citationParadoxical mood response following antidepressant withdrawal
GHADIRIAN, A. M. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90312-4 · Cited by 11 · see citing works
Psychotic Mania in Bipolar II Depression Related to Sertraline Discontinuation
Benazzi, F. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700621 · Cited by 9 · see citing works
Hypomania following withdrawal of trazodone
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1482b · Cited by 8 · see citing works
Flemmer, D. D., Dilsaver, S. C., & Peck, J. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90076-t · Cited by 8 · see citing works
Self-citationAnimal Models for the Symptoms of Mania
Lyon, M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-198-5:197 · Cited by 8 · see citing works
Behavioral effects of Bj-PRO-7a, a proline-rich oligopeptide from Bothrops jararaca venom
Turones, L. C., da Cruz, K. R., Camargo-Silva, G., Reis‐Silva, L. L., Graziani, D., Ferreira, P. M., Galdino, P. M., Pedrino, G. R., Santos, R. A. S., Costa, É. A., et al. (2019) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198441 · Cited by 7 · see citing works
Genetic Animal Models of Endogenous Depression
Overstreet, D. H. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6732-9_12 · Cited by 7 · see citing works
Minor Strokes Related to Paroxetine Discontinuation in an Elderly Subject: Emergent Adverse Events
Ramasubbu, R. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800415 · Cited by 6 · see citing works
Jaeckle, R. S., & Dilsaver, S. C. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb06229.x · Cited by 6 · see citing works
Self-citationUnipolare Depression – Pharmakotherapie und Psychotherapie (ICD-10 F3)
Schmauß, M., Schramm, E., & Berger, T. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50011-3 · Cited by 5 · see citing works
Medical Issues in the Care of Child and Adolescent Inpatients
Campo, J. V. (1993) · Springer eBooks · doi:10.1007/978-1-4899-2430-8_19 · Cited by 5 · see citing works
Cholinergic-monoamine systems, depression, and panic
Dilsaver, S. C. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90207-6 · Cited by 5 · see citing works
Self-citationMania induced by anti-depressant withdrawal
Dilsaver, S. C., & Greden, J. F. (1986) · Psychosomatics · doi:10.1016/s0033-3182(86)72610-8 · Cited by 3 · see citing works
Self-citationKassm, S. A., & Naja, W. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.080 · Cited by 3 · see citing works
Mania/hypomania associated with withdrawal of antidepressants
Güdü, M., Erensoy, İ. Y., & Ersümer, F. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2013260311 · Cited by 3 · see citing works
Pharmacologic Perturbation Strategies in the Study of the Neurobiology of Depression
Dilsaver, S. C. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90035-3 · Cited by 3 · see citing works
Self-citationA Clinical Overview of Syndromes Following Withdrawal of Antidepressants
McMahon, T. C. (1986) · Psychiatric Services · doi:10.1176/ps.37.9.883 · Cited by 2 · see citing works
Implications of perturbation strategies: A philosopher of science's perspective
Dilsaver, S. C. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90049-3 · Cited by 2 · see citing works
Self-citationCholinergic Supersensitivity in Affective Disorders
Dubé, S. (1993) · Springer eBooks · doi:10.1007/978-1-4757-9498-4_3 · Cited by 2 · see citing works
Wolf, M. A. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200205 · Cited by 2 · see citing works
The Phosphoinositide-Linked CNS Muscarinic Receptor
Agranoff, B. W., Fisher, S. K., Heacock, A. M., & Frey, K. A. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-5971-6_16 · Cited by 1 · see citing works
Muijen, M., Jones, D. P., Roy, D., Silverstone, T., & Mehmet, A. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90257-6 · Cited by 1 · see citing works
Kostarczyk, E., Fonberg, E., & Prechtl, J. C. (1986) · PubMed · Cited by 1 · see citing works
Unipolare Depression–Pharmakitherapie und Psychotherapie (ICD-10 F3)
Schmauß, M., Schramm, E., & Berger, T. (2008) · Elsevier eBooks · doi:10.1016/b978-343724780-4.50011-7
Does lithium stabilize muscarini receptors?
Dilsaver, S. C. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90186-6
Self-citationPharmacologic Mood Destabilization: Case Vignettes
Swann, A. C. (2009) · CNS Spectrums · doi:10.1017/s1092852900003898
Olası Paroksetin Tedavisinin Kesilmesi İle İlişkili İlk Atak Mani
Çam, B. (2015) · Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi) · doi:10.17826/cutf.38000
Lurasidone Induced Mania in a Case of Treatment Resistant Schizophrenia: A Case Report
Kumar, A. (2019) · Acta Scientific Neurology · doi:10.31080/asne.2019.02.0115
Schiffer, R. B., Klein, R. F., & Sider, R. C. (1988) · Springer eBooks · doi:10.1007/978-1-4899-0783-7_7
Rodier (1996) · doi:10.1002/(sici)1096-9861(19960624)370:2
- Authors
- Dilsaver, S. C., & Greden, J. F.
- Affiliations
- Michigan Medicine (US)
- University of Michigan (US)
- Corresponding author
- Dilsaver, Steven C.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 1984-03
- Volume
- 7
- Issue
- 1
- Pages
- 29-48
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2417584883
- Cited by
- 73
- References
- 207
- Citations by year
- 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- Brain Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- antidepressant discontinuation, hypomania, mania, behavioral arousal, EEG arousal, muscarinic receptors, lithium, electroconvulsive therapy, homeostatic mechanisms, depression, bipolar disorder
- MeSH terms
- Adrenergic Fibers, Animals, Antidepressive Agents, Arousal, Behavior, Animal, Bipolar Disorder, Brain, Cholinergic Fibers, Electroencephalography, Evoked Potentials, Humans, Sleep Stages, Substance Withdrawal Syndrome, Receptors, Neurotransmitter, Neurotransmitter Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review